| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4003321 | American Journal of Ophthalmology | 2012 | 10 Pages |
Abstract
Treatment of new neovascular AMD changed significantly between 2006 and 2008, most notably in the increasing use of anti-VEGF therapies. However, few patients treated with anti-VEGF medications received monthly injections, and discontinuation rates were high.
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Lesley H. Curtis, Bradley G. Hammill, Laura G. Qualls, Lisa D. Dimartino, Fang Wang, Kevin A. Schulman, Scott W. Cousins,